Mark Coleman

Insider Reports History

Entity
Individual
Location
25 Broadway, 9 Th Floor, New York, NY
Signature
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Coleman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Director Common Stock 404K $3.63M $9.00 Jan 3, 2025 Indirect
Axsome Therapeutics, Inc. Director Common Stock 57.1K $514K $9.00 Jan 3, 2025 Direct
Axsome Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Jan 3, 2025 Direct

Insider Reports Filed by Mark Coleman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXSM Axsome Therapeutics, Inc. Jan 3, 2025 2 $82.1K 4 Jan 6, 2025 Director
AXSM Axsome Therapeutics, Inc. Nov 19, 2024 2 $198K 4 Nov 20, 2024 Director
AXSM Axsome Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
AXSM Axsome Therapeutics, Inc. May 28, 2024 2 -$789K 4 May 29, 2024 Director
AXSM Axsome Therapeutics, Inc. Sep 15, 2023 4 -$2.18M 4 Sep 15, 2023 Director
AXSM Axsome Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 Director
AXSM Axsome Therapeutics, Inc. Mar 2, 2023 1 $0 4 Mar 6, 2023 Director
AXSM Axsome Therapeutics, Inc. Jan 3, 2023 2 $22.8K 4 Jan 4, 2023 Director
AXSM Axsome Therapeutics, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director
AXSM Axsome Therapeutics, Inc. Mar 15, 2022 2 $4.54K 4 Mar 17, 2022 Director
AXSM Axsome Therapeutics, Inc. Mar 4, 2022 1 $0 4 Mar 8, 2022 Director
AXSM Axsome Therapeutics, Inc. Nov 18, 2021 2 $50.2K 4 Nov 22, 2021 Director
AXSM Axsome Therapeutics, Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
AXSM Axsome Therapeutics, Inc. May 12, 2021 1 $29.1K 4 May 13, 2021 Director